Your browser doesn't support javascript.
loading
Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022.
van Loon, Welmoed; Bisimwa, Bertin C; Byela, Valéry; Kirby, Rebecca; Bugeme, Patrick M; Balagizi, Aimé; Lupande, David; Malembaka, Espoir B; Mockenhaupt, Frank P; Bahizire, Esto.
  • van Loon W; Institute of International Health, Center for Global Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Bisimwa BC; Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
  • Byela V; Institut Supérieur des Techniques Médicales de Bukavu, Bukavu, Democratic Republic of the Congo.
  • Kirby R; Institut Supérieur des Techniques Médicales de Bukavu, Bukavu, Democratic Republic of the Congo.
  • Bugeme PM; University of California, San Diego School of Medicine, San Diego, California.
  • Balagizi A; Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
  • Lupande D; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland.
  • Malembaka EB; Hôpital Général de Référence de Nyantende, Nyantende, Democratic Republic of the Congo.
  • Mockenhaupt FP; Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
  • Bahizire E; Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of the Congo.
Am J Trop Med Hyg ; 110(4): 653-655, 2024 Apr 03.
Article en En | MEDLINE | ID: mdl-38377612
ABSTRACT
Partial artemisinin resistance has emerged in East Africa, posing a threat to malaria control across the continent. The Democratic Republic of the Congo carries one of the heaviest malaria burdens globally, and the South Kivu province directly borders current artemisinin resistance hot spots, but indications of such resistance have not been observed so far. We assessed molecular markers of antimalarial drug resistance in 256 Plasmodium falciparum isolates collected in 2022 in South Kivu, Democratic Republic of the Congo. One isolate carried the P. falciparum Kelch-13 469Y variant, a marker associated with partial artemisinin resistance and decreased lumefantrine susceptibility in Uganda. In addition, the multidrug resistance-1 mutation pattern suggested increased lumefantrine tolerance.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Artemisininas / Antimaláricos Límite: Humans País como asunto: Africa Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Artemisininas / Antimaláricos Límite: Humans País como asunto: Africa Idioma: En Año: 2024 Tipo del documento: Article